Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 62, 100003
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30CA069533, P30EY010572, R01DC002368-15S1, R01HL132985)
This publication has 53 references indexed in Scilit:
- Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol LevelsJournal of Biological Chemistry, 2012
- A novel split kinesin assay identifies motor proteins that interact with distinct vesicle populationsJournal of Cell Biology, 2012
- Novel Domain Interaction Regulates Secretion of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) ProteinJournal of Biological Chemistry, 2011
- In Vivo Evidence That Furin from Hepatocytes Inactivates PCSK9Journal of Biological Chemistry, 2011
- Effects of the Prosegment and pH on the Activity of PCSK9Journal of Biological Chemistry, 2010
- Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor DegradationJournal of Biological Chemistry, 2009
- Self-Association of Human PCSK9 Correlates with Its LDLR-Degrading ActivityBiochemistry, 2008
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotypeProceedings of the National Academy of Sciences, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003